COX2 overexpression and excess PGE2 production were detected in HSCs in human NASH-triggered HCC, suggesting that the gut microbiota-driven COX2-PGE2-PTGER4 pathway may function in human NASH-associated HCC [118]. The gene discussed is PTGER4; the disease is metabolic dysfunction-associated steatohepatitis.